GIOVANNELLI, Simona
 Distribuzione geografica
Continente #
NA - Nord America 2.377
EU - Europa 2.330
AS - Asia 959
SA - Sud America 145
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.835
Nazione #
US - Stati Uniti d'America 2.345
IT - Italia 1.194
SG - Singapore 329
GB - Regno Unito 295
CN - Cina 263
IE - Irlanda 257
SE - Svezia 161
HK - Hong Kong 126
BR - Brasile 117
DE - Germania 115
VN - Vietnam 83
UA - Ucraina 68
RU - Federazione Russa 60
FI - Finlandia 38
FR - Francia 35
IN - India 35
NL - Olanda 33
TR - Turchia 32
BG - Bulgaria 22
ID - Indonesia 16
MX - Messico 15
CA - Canada 14
LT - Lituania 12
AR - Argentina 10
BD - Bangladesh 9
IQ - Iraq 9
IR - Iran 8
MY - Malesia 8
EG - Egitto 7
ES - Italia 7
EC - Ecuador 6
ZA - Sudafrica 6
KR - Corea 5
PL - Polonia 5
SA - Arabia Saudita 5
AL - Albania 4
CH - Svizzera 4
JP - Giappone 4
KE - Kenya 4
PH - Filippine 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
CO - Colombia 3
CZ - Repubblica Ceca 3
PT - Portogallo 3
UZ - Uzbekistan 3
VE - Venezuela 3
BE - Belgio 2
BO - Bolivia 2
BY - Bielorussia 2
CL - Cile 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
PK - Pakistan 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MA - Marocco 1
ME - Montenegro 1
MZ - Mozambico 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PY - Paraguay 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TN - Tunisia 1
UY - Uruguay 1
Totale 5.835
Città #
Santa Clara 262
Dublin 256
Ashburn 226
Singapore 213
Chandler 201
Southend 193
Fairfield 184
Woodbridge 141
Dearborn 134
Hong Kong 125
Jacksonville 114
Milan 107
Nyköping 98
Rome 89
Ann Arbor 84
Houston 84
Beijing 77
New York 72
Seattle 70
Wilmington 65
Cambridge 62
London 52
Naples 33
Bari 30
Bologna 30
Ho Chi Minh City 30
Munich 29
Los Angeles 28
Hefei 25
Florence 23
Izmir 22
Princeton 22
Turin 22
Eugene 21
Sofia 21
Helsinki 20
The Dalles 20
Palermo 19
San Diego 19
Hanoi 18
Modena 18
Dong Ket 16
Jakarta 15
Shanghai 15
Genoa 13
Moscow 13
Phoenix 11
São Paulo 11
Vicenza 11
Catania 10
Pisa 10
Boardman 9
Bremen 9
Padova 9
Denver 8
Ferrara 8
Guangzhou 8
Perugia 8
Redondo Beach 8
Venice 8
Verona 8
Brooklyn 7
Buffalo 7
Columbus 7
Council Bluffs 7
Fremont 7
San Mateo 7
Trieste 7
Ancona 6
Brescia 6
Cagliari 6
Chennai 6
Dallas 6
Monte Porzio 6
Norwalk 6
Orem 6
Porto Alegre 6
Redwood City 6
Reggio Emilia 6
Turku 6
Des Moines 5
Lecce 5
Montreal 5
Sassari 5
Atlanta 4
Augusta 4
Bergamo 4
Bitritto 4
Elk Grove Village 4
Falls Church 4
Gallarate 4
Johannesburg 4
Kunming 4
Querétaro 4
Ravenna 4
San Giovanni Valdarno 4
Stockholm 4
Tirana 4
Warsaw 4
Ankara 3
Totale 3.771
Nome #
VALORE PROGNOSTICO E PREDITTIVO DI p53 NEL CARCINOMA MAMMARIO TRATTATO CON CHEMIOTERAPIA NEOADIUVANTE 1.016
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVO 432
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 367
Letrozole Versus Letrozole Plus Lapatinib (GW572016) in Hormone-Sensitive, HER2-Negative Operable Breast Cancer: A Double-Blind, Randomized Phase II Study with Biomarker Evaluation (EGF109077-LAP107692/LETLOB) 325
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer. 320
MODULAZIONE DELL’ESPRESSIONE DI BIOMARCATORI E PROGNOSI IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO OPERABILE SOTTOPOSTE A CHEMIOTERAPIA PREOPERATORIA 311
A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy 301
Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis 279
A prognostic model based on nodal status and Ki 67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy 265
Preoperative chemotherapy plus lapatinib or trastuzumab or both in Her2 positive operable breast cancer. EGF109085-LAP106988/CHERLOB Trial. 254
Preliminary safety data of preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer 225
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS 195
Biomarker expression and survival after primary chemotherapy for breast cancer. 193
Primary systemic therapy for operable breast cancer: a review of clinical trials and perspectives 193
LAPATINIB IN ASSOCIAZIONE A CAPECITABINA IN PAZIENTI CON CARCINOMA MAMMARIO METASTTICO HER2 POSITIVO IN PROGRESSIONE DOPO TERAPIA CON TRASTUZUMAB 185
IMPROVED SURVIVAL AFTER RADIOTHERAPY FOR BRAIN METASTASES IN PATIENTS WITH HER2 POSITIVE BREAST TUMORS 185
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVE: ANALISI PRELIMINARE DELLE TOSSICITA’ 184
CARCINOMI MAMMARI HER2 POSITIVI: CASISTICA DI MODENA 171
Operable Breast Cancer: preliminary results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarkers evaluation 168
CHEMOTHERAPY-INDUCED MODULATION OF BIOMARKERS EXPRESSION IN PRIMARY BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY 157
VALUTAZIONE DEL RISCHIO DI TOSSICITA’ CARDIACA DI TRASTUZUMAB IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO IN TRATTAMENTO ADIUVANTE 132
Totale 5.858
Categoria #
all - tutte 17.233
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.233


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021251 0 0 0 0 0 22 52 42 38 28 40 29
2021/2022381 8 49 53 13 7 23 20 9 50 16 88 45
2022/2023866 81 76 29 64 52 67 13 48 310 30 59 37
2023/2024766 36 45 44 48 82 68 53 111 38 69 88 84
2024/20251.328 57 65 45 129 220 193 80 96 171 66 74 132
2025/2026931 128 67 123 228 340 45 0 0 0 0 0 0
Totale 5.858